8-K: Current report filing
Published on May 16, 2003
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 15, 2003
Access Pharmaceuticals, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-9314 83-0221517
- ------------------------ ------------------------ -------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
2600 Stemmons Freeway, Suite 176, Dallas, Texas 75207
----------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (214) 905-5100
--------------
Not applicable
-------------------------------------------------------------
(Former name or former address; if changed since last report)
Item 5. Other Events.
The registrant hereby incorporates by reference the press release
dated March 31, 2003 attached hereto as Exhibit 99.1 ("Access
Pharmaceuticals, Inc. Announces First Quarter Financial Results")
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
Exhibit
Number Description
- ------- ------------
99.1 Press Release dated May 15, 2003 - "Access
Pharmaceuticals, Inc. Announces First Quarter Financial Results"
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Access Pharmaceuticals, Inc.
(Registrant)
By: /s/ Kerry P. Gray
------------------
Kerry P. Gray
President and CEO
Dated May 16, 2003
3
EXHIBIT INDEX
Exhibit
Number Description
- ------- ------------
99.1 "Access Pharmaceuticals, Inc. Announces First
Quarter Financial Results"
4